Brooks Laboratories Limited — Board Meeting, 17-12-2024: Outcome of Board Meeting

The Fund Raising Committee of Brooks Laboratories has convened and approved a preferential issue of up to 35,33,520 equity shares at an issue price of Rs. 141.50 each, totaling approximately Rs. 49.99 Cr. This move is intended for non-promoter investors and is subject to shareholder approval in an upcoming Extraordinary General Meeting (EGM). The committee also authorized the appointment of a scrutinizer for the EGM and granted powers to the Whole-Time Director and CFO to manage all necessary documentation and approvals related to this issuance. Trading in the company's equity shares will be suspended for 48 hours following this announcement.